SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

NCT00015899 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: lonafarnib

Sponsor

Pediatric Brain Tumor Consortium

Collaborators

[object Object]